DT

DEEMA TARAZI

BROWNSTEIN HYATT FARBER SCHRECK, LLP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
32
last 3 years
Filings
88
13 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
Health Issues · 2024 Q3
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Pharmacy · 2024 Q3
Health technology and Artificial Intelligence
Health Issues · 2024 Q3
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act
Pharmacy · 2024 Q3
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues S. 476/H.R.5547 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues
Health Issues · 2024 Q3
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of Inflation Reduction Act of 2022 HELP Copays Act
Health Issues · 2024 Q3

Clients

2024 · 4 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock

Filing history

2024 Q3
ELI LILLY AND COMPANY
Q3lda.gov →
2024 Q3
RELX INC
Q3lda.gov →
2024 Q3
NOVARTIS
3Alda.gov →
2024 Q3
CENCORA, INC.
Q3lda.gov →
2024 Q3
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA
Q3lda.gov →
2024 Q3
MODERNA US INC.
Q3lda.gov →
2024 Q3
PARTICLE HEALTH
Q3lda.gov →
2024 Q3
KNOA PHARMA, FORMERLY REPORTED AS, PURDUE PHARMA L.P.
Q3lda.gov →
2024 Q3
HARMONY BIOSCIENCES
Q3lda.gov →
2024 Q3
LIFEPOINT HEALTH
Q3lda.gov →
2024 Q3
NOVARTIS
Q3lda.gov →
2024 Q3
ABBVIE
Q3lda.gov →
Showing recent filings · full history on lda.gov